COLLINS FOMUNUNG: Open Payments
NPI 1124414750 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 36 payments from 11 companies in 2025. Trend: 2023 $573 · 2024 $1,186 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $299 |
| Janssen Pharmaceuticals, Inc | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Cipher Pharmaceuticals US LLC | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, REXULTI, COBENFY, Natroba, Secuado, ARISTADA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
